You just read:

Interim analysis from EMPRISE real-world study shows Jardiance® decreased risk of hospitalization for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists

News provided by

Eli Lilly and Company

Nov 17, 2019, 10:50 ET